Healthcare Services

Cardiac troponin market outlook (2026–2030)

April 20, 2026April 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Does The Market Size Of The Cardiac Troponin Market Compare Between 2026 And 2030?

The cardiac troponin market has demonstrated rapid expansion in recent years. It is anticipated to increase from $4.24 billion in 2025 to $4.68 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.4%. Factors contributing to its expansion in the past include a rise in the prevalence of acute coronary syndromes, the broadening of emergency cardiac care services, the embrace of biomarker-based diagnostics, enhancements in laboratory testing accuracy, and the development of hospital diagnostic infrastructure.

The market for cardiac troponin is projected to experience swift expansion over the coming years, reaching a valuation of $6.92 billion by 2030, driven by a compound annual growth rate (CAGR) of 10.3%. This anticipated growth during the forecast timeframe is attributable to several factors, including a heightened demand for swift cardiac diagnostic tools, an increasing embrace of decentralized testing methods, the broadening scope of home-based cardiac monitoring, the expanding utilization of AI-powered diagnostic interpretation, and a greater emphasis on early intervention approaches. Key trends anticipated within this period encompass the growing acceptance of high-sensitivity troponin assays, the increased application of point-of-care cardiac testing, the deepening integration of automated laboratory diagnostics, an expansion of quick rule-in and rule-out procedures, and a heightened concentration on detecting cardiac injury early.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/cardiac-troponin-global-market-report

What Key Factors Are Shaping The Cardiac Troponin Market Landscape?

The rising occurrence of cardiovascular ailments is anticipated to drive expansion in the cardiac troponin market in the future. These conditions cover various cardiovascular illnesses such as coronary artery disease, heart failure, arrhythmias, and congenital heart defects, which impact the heart’s structure and how it functions. The growing incidence of heart-related conditions stems from factors like an aging demographic, inactive routines, unhealthy eating patterns, and increasing levels of obesity and hypertension. Cardiac troponin plays a vital role in diagnosing these conditions, acting as a very sensitive biomarker to identify damage to the heart muscle, especially during heart attacks and similar cardiac incidents. For example, in October 2024, the Centers for Disease Control and Prevention, a US-based federal agency, reported that in 2023, 919,032 individuals succumbed to cardiovascular disease. This figure represents 1 in every 3 deaths. Consequently, the expanding occurrence of heart-related conditions will boost the growth of the cardiac troponin market.

What Are The Main Segments Within The Cardiac Troponin Market Segment Structure?

The cardiac troponin market covered in this report is segmented –

1) By Type: Troponin I, Troponin T

2) By Location Of Testing: Laboratory Setting, Point Of Care (Poc) Testing

3) By Application: Acute Coronary Syndrome, Myocardial Infraction

4) By End User: Hospitals, Diagnostic Centers

Subsegments:

1) By Troponin I: Conventional Cardiac Troponin I (cTnI), High-Sensitivity Cardiac Troponin I (hs-cTnI)

2) By Troponin T: Conventional Cardiac Troponin T (cTnT), High-Sensitivity Cardiac Troponin T (hs-cTnT)

What Market Trends Are Affecting The Cardiac Troponin Market?

Major companies operating in the cardiac troponin market are concentrating on innovating new technologies, such as human serum-based quality control, to ensure accurate and dependable high-sensitivity troponin testing by providing multi-analyte controls. This human serum-based quality control for cardiac troponin testing assures test accuracy and reliability by utilizing human serum with known troponin concentrations to verify the assay’s performance. For instance, in May 2023, Bio-Rad Laboratories, Inc., a US-based biotechnology research company, launched Cardiac Advance, a four-level, multi-analyte quality control specifically designed for high-sensitivity troponin testing. These liquid, human-serum-based controls are available in InteliQ 3-mL tubes, Liquichek 3-mL standard, and 2.5-mL compact vials. The controls include 10 cardiac analytes, such as troponin, CK-MB, BNP/proBNP, and myoglobin, and are compatible with Siemens and Roche testing platforms. These products are offered in the U.S., Europe, and selected Asian markets.

Who Are The Companies Participating In The Cardiac Troponin Market?

Major companies operating in the cardiac troponin market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Becton Dickinson and Company, Laboratory Corporation of America Holdings (Labcorp), bioMérieux SA, Beckman Coulter Inc., QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Radiometer Medical ApS, Randox Laboratories Ltd., Fujirebio Diagnostics Inc., Meso Scale Diagnostics LLC., Singulex Inc., Diazyme Laboratories Inc., Response Biomedical Corporation, Eurolyser Diagnostica GmbH, LifeSign LLC

Get The Full Cardiac Troponin Market Report:

https://www.thebusinessresearchcompany.com/report/cardiac-troponin-global-market-report

Which Region Leads The Cardiac Troponin Market In Terms Of Market Share?

North America was the largest region in the cardiac troponin market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac troponin market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Cardiac Troponin Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/cardiac-troponin-global-market-report

Browse Through More Reports Similar to the Global Cardiac Troponin Market 2026, By The Business Research Company

Structural Heart Market Report 2026

https://www.thebusinessresearchcompany.com/report/structural-heart-global-market-report

Cardiac Valve Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiac-valve-global-market-report

Cardiac Biomarkers Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795